Defence announces Dr Maxime Parisotto as CSO, Director of Science and Business Development

Dr Maxime Parisotto is a seasoned biochemist with over 20 years of experience spanning academic research, drug development, and innovation.
US announces $70.8M funding boost for EV battery recycling and manufacturing modernisation

US announces $70.8M funding boost for EV battery recycling and manufacturing modernisation

The US has announced $70.8m funding to optimise the nation’s EV ecosystem. Learn how this investment will boost recycling and manufacturing.
bio-based chemicals

Why bio-based chemicals and materials face a higher entry to market bar than fossil...

BBIA highlights the potential for bio-based chemicals to reduce greenhouse gases and emphasises the UK’s opportunity to lead in this sector.
antibiotic resistance

Antibiotic resistance: 100 years of history

QURES Group offers a nature-inspired approach to effectively combat antibiotic resistance. Find out more now.

Unveiling the secrets of the Higgs Boson: The ATLAS Collaboration’s latest insights and measurements

CERN’s Katharine Leney discusses the ATLAS Collaboration’s latest findings and their implications for understanding the Higgs boson.
cancer research

Oncopole: Québec’s catalyst for cancer research and innovation

Oncopole drives cancer research in Québec, uniting partners to accelerate innovation in treatment, prevention, and patient care.
chemical industry

Driving net zero emissions in the chemical industry

Charlie Tan, CEO of Global Impact Coalition, discusses shaping the chemical industry by addressing systemic barriers and advancing solutions.
antimicrobial technologies

Quick-Med Technologies: Sustainable antimicrobial technologies for a healthier future

Quick-Med's antimicrobial platforms, NIMBUS and Stay-Fresh, eliminate highly resistant bacteria fast enough to prevent healing interference.
Oak Hill Bio and Chiesi enrol first European patient in bronchopulmonary dysplasia treatment study

Oak Hill Bio and Chiesi enrol first European patient in bronchopulmonary dysplasia treatment study

Oak Hill Bio and Chiesi Group have launched a study of a revolutionary bronchopulmonary dysplasia treatment for extremely premature infants.
research and innovation

Research and innovation at Niagara College: Solutions for industry

Niagara College provides real-world solutions for businesses, key industry sectors, and the community through applied research and knowledge.